PUBLIC CONTRACT · 2024
Aquisição do medicamento OLIPUDASE ALFA 20 mg Pó sol inj Fr IV, para doente específico
- Contract value
- €104,704.80
- Signed on
- 6 June 2024
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10763744PUBLISHED SUBJECT
Aquisição do medicamento OLIPUDASE ALFA 20 mg Pó sol inj Fr IV, para doente específico
Parties involved
- Place of performance
- Portugal, Porto, Porto
- NUTS region
- PT11A - Área Metropolitana do Porto
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- Sanofi - Produtos Farmacêuticos, Lda. · Tax ID 500134960
Values and timeline
- Contract price
- €104,704.80
- Procedure base price
- €104,704.80
- Total effective price
- Not reported on Portal BASE
- Publication date
- 12 June 2024
- Award date
- 6 June 2024
- Signing date
- 6 June 2024
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Monofator
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea c) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 7087432
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.